The Role of Community Pharmacy Personnel in Tuberculosis Case Detection: A Narrative Review

Carla Florencia; Ida Ayu Andri Parwitha; Dian Ayu Eka Pitaloka; Ivan Surya Pradipta

doi:10.52434/jifb.v17i2.42197

Authors

Carla Florencia Universitas Padjadjaran
Ida Ayu Andri Parwitha Universitas Padjadjaran
Dian Ayu Eka Pitaloka Universitas Padjadjaran
Ivan Surya Pradipta Universitas Padjadjaran

DOI:

https://doi.org/10.52434/jifb.v17i2.42197

Keywords:

case detection, community pharmacist, pharmacy, tuberculosis

Abstract

Tuberculosis (TB) continues to pose a global health challenge, mainly due to low case detection rates in high-burden countries like Indonesia. Community pharmacies (CP), the health facilities most commonly visited by individuals experiencing tuberculosis symptoms, play an essential role in early detection and referral to health facilities. This narrative review examines the role of community pharmacists in TB case detection through pharmacy-based interventions in developing countries with high TB burden. The following databases were used to identify articles that met the inclusion and exclusion criteria: PubMed and Scopus. Based on three eligible studies from India, Pakistan, and Cambodia, pharmacy-based TB case detection programs were associated with increased case detection and referral of presumptive TB cases. The included studies reported that structured interventions, including pharmacist training, referral systems, monitoring, and public-private collaboration, may support TB case detection in high-burden settings. However, several barriers were identified, including uncertainty about referral pathways, financial constraints, and concerns about service quality at referral facilities. Given the limited evidence from only three studies, these findings should be interpreted cautiously, and further research is needed to assess the effectiveness and sustainability of pharmacy-based TB case-detection programs. CP engagement may contribute to TB case detection when reinforced by well-defined, structured referral pathways and integration with public-private TB control initiatives.

References

1. World Health Organization (WHO). Global tuberculosis report 2024. GENEVA: Geneva, Switzerland: World Health Organization; 2024. 50 p.

2. Sulistyo, Utami ASF, Wicaksono AB, Salsabila A. Laporan program penanggulangan tuberkulosis tahun 2021. Kemenkes RI. Jakarta, Indonesia: Kementerian Kesehatan Republik Indonesia; 2023. 1–130 p.

3. Lestari BW, McAllister S, Hadisoemarto PF, Afifah N, Jani ID, Murray M, et al. Patient pathways and delays to diagnosis and treatment of tuberculosis in an urban setting in Indonesia. Lancet Reg Heal - West Pacific. 2020 Dec;5:100059.

4. Fuady A, Houweling TAJ, Mansyur M, Burhan E, Richardus JH. Cost of seeking care for tuberculosis since the implementation of universal health coverage in Indonesia. BMC Health Serv Res. 2020 Dec 3;20(1):1–10.

5. Surya A, Setyaningsih B, Suryani Nasution H, Gita Parwati C, Yuzwar YE, Osberg M, et al. Quality tuberculosis care in Indonesia: using patient Pathway analysis to optimize public–private collaboration. J Infect Dis. 2017 Nov 6;216(suppl_7):S724–32.

6. Rahmadani I, Surjoputro A, Widjanarko B. Analisis public private mix (PPM) pada program pengendalian tuberkulosis. J Kesmas (Kesehatan Masyarakat) Khatulistiwa. 2020 Sep 15;7(3):89–97.

7. Pariyana, Mariana, Liana Y. Perilaku swamedikasi masyarakat pada masa pandemi Covid-19 di kota Palembang. In: Prosiding Seminar Nasional STIKES syedza Saintika. Padang, Indonesia: STIKES Syedza Saintika; 2021. p. 403–15.

8. World Health Organization. The role of pharmacists in tuberculosis care and control [Internet]. World Health Organization. Hyderabad; 2011. Available from: https://www.fip.org/files/fip/WHO/Signing ceremony_WHOFIPJointStatement.pdf

9. Pradipta IS, Yanuar EO, Nurhijriah CY, Maharani NP, Subra L, Destiani DP, et al. Practical models of pharmaceutical care for improving tuberculosis Patient detection and treatment outcomes: A systematic scoping review. Trop Med Infect Dis. 2023 May 20;8(5):287.

10.Daftary A, Satyanarayana S, Jha N, Singh M, Mondal S, Vadnais C, et al. Can community pharmacists improve tuberculosis case finding? A mixed methods intervention study in India. BMJ Glob Heal [Internet]. 2019 May 13;4(3):1–10.

11.Ullah W, Almansour H, Fatima R, Saini B, Khan GM. Engaging community pharmacies in early detection of missing tuberculosis patients through public–private mix intervention in Pakistan. Am J Trop Med Hyg. 2020 Jul 8;103(1):221–30.

12.Bell CA, Ilomäki J, Pichenda K, Duncan GJ, Saini B. Referral of tuberculosis symptomatic clients from private pharmacies to public sector clinics for diagnosis and treatment in Cambodia. J Eval Clin Pract [Internet]. 2015 Apr 5;21(2):285–91.

13.Abdulah R, Barliana MI, Pradipta IS, Halimah E, Diantini A, Lestari K. Assessment of patient care indicators at community pharmacies in Bandung City, Indonesia. Southeast Asian J Trop Med Public Health. 2014;45(5):1196–1201.

14.Pradipta IS, Khairunnisa K, Bahar MA, Kausar MN, Fitriana E, Ruslami R, et al. Knowledge, attitude, and practice of community pharmacy personnel in tuberculosis patient detection: a multicentre cross-sectional study in a high-burden tuberculosis setting. BMJ Open. 2022 Jul 5;12(7):e060078.

15.Satyanarayana S, Kwan A, Daniels B, Subbaraman R, McDowell A, Bergkvist S, et al. Use of standardised patients to assess antibiotic dispensing for tuberculosis by pharmacies in urban India: a cross-sectional study. Lancet Infect Dis. 2016;16(11).

16.Zawahir S, Le H, Nguyen TA, Beardsley J, Duc AD, Bernays S, et al. Standardised patient study to assess tuberculosis case detection within the private pharmacy sector in Vietnam. BMJ Glob Heal. 2021 Oct;6(10):1–11.